ketoconazole and azamulin

ketoconazole has been researched along with azamulin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blanchard, AP; Broudy, MI; Cargill, CE; Crespi, CL; Dandeneau, AA; Dehal, SS; Erve, JC; Goodwin, JJ; Ho, T; Patten, CJ; Sharma, R; Stresser, DM; Turner, SD	1
Alton, KB; Chowdhury, SK; Ghosal, A; Hapangama, N; Kishnani, NS; Ramanathan, R; Yuan, Y	1

Other Studies

2 other study(ies) available for ketoconazole and azamulin

Article	Year
Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible. Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:1 Topics: Anti-Infective Agents; Bridged-Ring Compounds; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fluorometry; Humans; In Vitro Techniques; Ketoconazole; Microsomes, Liver; NADP; Pleurotus; Solubility; Steroid Hydroxylases; Substrate Specificity; Triazoles; Xenobiotics	2004
Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist. Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:12 Topics: Antibodies, Monoclonal; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bridged-Ring Compounds; Carboxylic Acids; CCR5 Receptor Antagonists; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dealkylation; Enzyme Inhibitors; Humans; Immunologic Factors; In Vitro Techniques; Isoenzymes; Ketoconazole; Kinetics; Liver; Oxidation-Reduction; Piperazines; Pyrimidines; Recombinant Proteins; Substrate Specificity; Testosterone; Triazoles	2007

Article

Year

Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible.

Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:1

Topics: Anti-Infective Agents; Bridged-Ring Compounds; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fluorometry; Humans; In Vitro Techniques; Ketoconazole; Microsomes, Liver; NADP; Pleurotus; Solubility; Steroid Hydroxylases; Substrate Specificity; Triazoles; Xenobiotics

2004

Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist.

Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:12

Topics: Antibodies, Monoclonal; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bridged-Ring Compounds; Carboxylic Acids; CCR5 Receptor Antagonists; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dealkylation; Enzyme Inhibitors; Humans; Immunologic Factors; In Vitro Techniques; Isoenzymes; Ketoconazole; Kinetics; Liver; Oxidation-Reduction; Piperazines; Pyrimidines; Recombinant Proteins; Substrate Specificity; Testosterone; Triazoles

2007